The FDA this week released draft guidance covering uncertainty in making benefit-risk determinations for certain medical devices, laying out the factors that the agency considers for such determinations.
At the top of the agency’s list are considering “the extent of the probably benefits of the device, including type, magnitude, probability, duration and frequency of those benefits,” according to the draft guidance. The same consideration is applied to risks, including severity, type, number, rates, probability and duration.